Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Half Dose Concomitant Therapy in H. Pylori Infection
NCT01219764Phase 4Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Oct 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rabeprazole, amoxicillin, clarithromycin, metronidazole in Helicobacter pylori infection, sponsored by American University of Beirut Medical Center. Started Oct 2010; status: completed.
02
Drugs
rabeprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01219764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219764.